Barely Significant
← all excerpts

Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function.

J Hypertens · 2014 · PMC3914904 · PMID 24309493

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
When both drugs were used in combination, there was a highly significant reduction in SBP compared with control (167.1 ± 2.9 mmHg, P < 0.001), which was significantly lower than either treatment alone.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.